Skip to main content
Log in

Vitamin D insufficiency as a determinant of hip fractures

  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Cooper C, Campion G, Melton LJ. Hip fractures in the elderly: a world wide projection. Osteoporosis Int 1992;2:285–9.

    Google Scholar 

  2. Melton LJ, Wahner HW, Richelson LS, O'Fallon WM, Riggs BL. Osteoporosis and the risk of hip fractures. Am J Epidemiol 1986;124:254–51.

    Google Scholar 

  3. Cummings SR, Black DM, Nevitt MC, Johnell O, Genant HK. Bone density at various sites for prediction of hip fracture. Lancet 1993;341:72–5.

    Google Scholar 

  4. Riggs BL, Melton LJ III. Involutional osteoporosis. N Engl J Med 1986;314:1676–86.

    Google Scholar 

  5. Riggs BL, Melton LJ III. Clinical heterogeneity of involutional osteoporosis: implications for preventive therapy. J Clin Endocrinol Metab 1990;70:1229–32.

    Google Scholar 

  6. Bullamore JR, Wilkinson R. Gallagher JC, Nordin BEC. Effect of age on calcium absorption Lancet 1970;II:535–7.

    Google Scholar 

  7. Epstein S, Bryce G, Hinman JW, Miller ON, Riggs BL, Hui SL, Johnson CC. The influence of age on bone mineral regulating hormones Bone 1986;7:421–6.

    Google Scholar 

  8. Parfitt AM, Matthews C, Rao D, Frame B, Klerekoper M, Villanueva AR. Impaired osteoblast function in metabolic bone disease. In: DeLuca HF, Frost HM, Jee WSS, Johnston CC, Parfitt AM, editors. Osteoporosis: recent advances in pathogenesis and treatment. Baltimore: University Park Press, 1981:321–42.

    Google Scholar 

  9. Quesada JM, Coopmans W, Ruiz P, Aljama O, Jans I, Bouillon R. Influence of vitamin D on parathyroid function in the elderly. J Clin Endocrinol Metab 1992;75:494–501.

    Google Scholar 

  10. Bouillon R, Auxwerx J, Lissens W, Pelemans W. Vitamin D status in the elderly: seasonal substrate deficiency causes 1,25-dihydroxycholecalciferol deficiency. Am J Clin Nutr 1987;45:755–63.

    Google Scholar 

  11. Holick MF. Vitamin D requirements for the elderly. Clin Nutr 1986;5:121–9.

    Google Scholar 

  12. McKenna MJ. Differences in vitamin D status between countries in young adults and in elderly. Am J Med 1992;93:69–77.

    Google Scholar 

  13. Bouillon R, Pelemans W, Quesada JM. Vitamin D deficiency in elderly. In Burckhardt P, editor. Nutritional aspects of osteoporosis. New York: Raven Press, 1991: 245–54.

    Google Scholar 

  14. Van der Wielen RP, Löwick MRH, Van der Berg H, LCPGM De Groot, Haller J, Moreiras O, van Staveren WA. Serum vitamin D concentrations among elderly people in Europe. Lancet 1995;346:207–10.

    Google Scholar 

  15. Sherman SS, Hollis BW, Tobin JD. Vitamin D status and related parameters in a healthy population: the effects of age, sex and season. J Clin Endocrinol Metab 1990;71:405–13.

    Google Scholar 

  16. Quesada Gomez JM, Alonso J, Jans I, Bouillon R. Metabolismo de la vitamina D en ancianos: evidencia de síntesis adecuada de 1,25(OH)2D3. Rev Clin Esp 1989;185:436–9.

    Google Scholar 

  17. Parffit AM, Gallagher JC, Heaney RP, Johnston CC, Neer R, Whedon GD. Vitamin D and bone health in the elderly. Am J Clin Nutr 1982;36:1014–31.

    Google Scholar 

  18. Slovik DM, Adams JM, Neer RM, Holick MF, Potts JT Jr. Deficient production of 1,25-dihydroxyvitamin D in elderly patients. N Engl J Med 1981;305:372–4.

    Google Scholar 

  19. Eastell R, Yergey AL, Vieira NE, Cedel SL, Kumar R, Rigss BK. Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function, and age in woman: evidence of an age-related intestinal resistance to 1,25-dihydroxyvitamin D action. J Bone Miner Res 1991;6:125–320.

    Google Scholar 

  20. Tsai KS, Health H III, Kumar R, Riggs BL. Impaired vitamin D metabolism with aging in women: possible role in pathogenesis of senile osteoporosis. J Clin Invest 1984;73:1668–72.

    Google Scholar 

  21. Dandona P, Menon RK, Shenoy R, Houlder S, Thomas M, Mallinson WJW. Low 1,25-dihydroxyvitamin D, secondary hyperparathyroidism, and normal osteocalcin in elderly subjects. J Clin Endocrinol Metab 1986;63:459–61.

    Google Scholar 

  22. Ebeling PR, Sandgren ME, DiMagno EP, Lane AW, DeLuca HF, Riggs BL. Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25-dihydroxyvitamin D3 and intestinal vitamin D receptor concentrations in normal women. J Clin Endocrinol Metab 1992;75:176–82.

    Google Scholar 

  23. Riggs LB, Hamstra A, De Luca HF. Assessment of 25-hydroxyvitamin D-1α hydroxylase reserve in postmenopausal osteoporosis by administration of parathyroid extract. J Clin Endocrinol Metab 1982;54:1258–61.

    Google Scholar 

  24. Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest 1979;64:729–36.

    Google Scholar 

  25. Clemens TL, Zhov XY, Myles M, Endres D, Lindsay R. Serum vitamin D2 and vitamin D3 metabolite concentrations and absorption of vitamin D2 in elderly subjects. J Clin Endocrinol Metab 1986;63:656–60.

    Google Scholar 

  26. Orwol ES, Meier DE. Alteration in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: relationship to the development of senile osteopenia. J Clin Endocrinol Metab 1986;63:1262–9.

    Google Scholar 

  27. Quesada JM, Jans I, Benito P, Jimenez JA, Bouillon R. Vitamin D status of elderly people in Spain. Age Ageing 1989;18:392–7.

    Google Scholar 

  28. Gennari C, Agnusdei D, Nardi P, Civitelli R. Estrogen preserves a normal intestinal responsiveness to 1,25-dihydroxyvitamin D3 in oophorectomized women. J Clin Endocrinol Metab 1990;71:1288–93.

    Google Scholar 

  29. Wiske PS, Epstein S, Bell NH, Queener SH, Edmonson J, Johnston JC. Increases in immunoreactive parathyroid hormone with age. N Engl J Med 1979;300:1419–21.

    Google Scholar 

  30. Marcus R, Madvig P, Young G. Age related changes in parathyroid hormone action in normal humans. J Clin Endocrinol Metab 1984;58:223–9.

    Google Scholar 

  31. Chapuy MC, Durr F, Chapuy P. Aged related changes in parathyroid hormone and 25-hydroxycholecalciferol levels. J Gerontol 1983;38:19–22.

    Google Scholar 

  32. Endress DB, Morgan CH, Garry PJ, Omdahl JH. Age-related changes in serum immunoreactive parathyroid hormone and its biological action in healthy men and women. J Clin Endocrinol Metab 1987;65:724–31.

    Google Scholar 

  33. Lips P, Netelembos JC, Jongen MJC, Van Ginkel FC, Althius AL, Van Schaik CL, Van der Vijgh WJ, Vermeiden JP, Van der Neer C. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 1988;67:644–50.

    Google Scholar 

  34. Ledger GA, Burritt MF, Kao PC, O'Fallon WM, Riggs BL, Khosla S. Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab 1995;79:211–6.

    Google Scholar 

  35. Barger-Lux MJ, Heaney RP, Lanspa SJ, Healy JC, De Luca HF. An investigation of sources of variation in calcium absorption efficiency. J Clin Endocrinol Metab 1995;80:406–11.

    Google Scholar 

  36. Francis RM, Peacock M, Storer JH, Davies AEJ, Brown WB BEC. Calcium malabsorption in the elderly: the effect of treatment with oral 25-hydroxyvitamin D3. Eur J Clin Invest 1983;13:391–6.

    Google Scholar 

  37. Naveh-Many T, Kilav R, Silver J. Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression in the parathyroid gland. In: Norman AW, Bouillon R, Thomasset M, editors. Vitamin D: gene regulation, structure function analysis and clinical application. Berlin: Walter de Gruyter, 1991:75–81.

    Google Scholar 

  38. Silver J, Naveh-Many T, Mayer H, Smelzer S, Popovtzer MM. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest 1986;78:1296–31.

    Google Scholar 

  39. Naveh-Many T, Marks R, Keshet E, Pike JW, Silver J. Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo. J Clin Invest 1990;86:1968–75.

    Google Scholar 

  40. Naveh-Many T, Silver J. Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia and vitamin D in the rat. J Clin Invest 1990;86:1313–9.

    Google Scholar 

  41. Amorim-Cruz JA, Moreiras Varela O, van Staveren WA, Trichopoulo A, Roszkowski W. Euronut SENECA study on nutrition in the elderly: intake of vitamin Ds and minerals. Eur J Clin Nutr 1991;45:125–38.

    Google Scholar 

  42. Parfitt AM. Osteomalacia and related disorders. In: Avioli LV, Krane SM, editors. Metabolic bone disease and clinical related disorders. Philadelphia: WB Saunders, 1990:329–96.

    Google Scholar 

  43. Lips P, Netelembos JC, Jongen MJM, Van Ginkel FC, Althius AI, Van Chsik CL, Van der Vijgh WJ, Veremeiden JP, Van der Maer C. Histomorphometric profile and vitamin D status in patients with femoral neck fracture. Metab Bone Dis Rel Res 1982;4:85–92.

    Google Scholar 

  44. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum under-carboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993;91:1768–74.

    Google Scholar 

  45. Khaw KT, Sneyd MJ, Compston J. Bone density, parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women. BMJ 1992;305:2273–6.

    Google Scholar 

  46. Villarreal DT, Civitelli R, Chines A, Avioli LV. Subclinical vitamin D deficiency in postmenopausal women with low vertebral bone mass. J Clin Endocrinol Metab 1991;72:628–34.

    Google Scholar 

  47. Gonzalez-Dominguez J, Martinez Concha D, Caracuel MA, Gonzalez-Perez I, Gines-Martinez F, Gala M, Quesada JM. Estudio epidemiologico de las fracturas de cadera en la provincia de Córdoba. Rev Esp Reumatol 1995;22:10–4.

    Google Scholar 

  48. Jacobson SJ, Goldberg J, Miles TP, Brody JA, Stiers W, Rimm AA. Seasonal variation in the incidence of hip fracture among white persons aged 65 years and older in the United States. Am J Epidemiol Rev 1991;133:996–1004.

    Google Scholar 

  49. Aiken JM, Anderson JB. Seasonal variations in bone mineral content after the menopause. Nature 1973;241:59–60.

    Google Scholar 

  50. Dawson-Hughes B, Dallal GE, Krall EA, Harris S, Sokoll LJ, Falconer G. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med 1991;115:505–12.

    Google Scholar 

  51. Falch JA, Mowé M, Bomer T, Haug E. Serum levels of intact parathyroid hormone in elderly patients with hip fracture living at home. Acta Endocrinol 1992;126:10–2.

    Google Scholar 

  52. Compston JE, Silver AC, Croucher PI, Brown RC, Woodhead JS. Elevated serum intact parathyroid hormon levels in elderly patients with hip fracture. Clin Endocrinol 1989;31:667–72.

    Google Scholar 

  53. Brown IRF, Bakowska A, Millard PH. Vitamin D status of patients with femoral neck fractures. Age Ageing 1976;5:127–31.

    Google Scholar 

  54. Cooper C, McLaren M, Wood PJ, Coulton L, Kanis JA. Indices of calcium metabolism in women with hip fractures. Bone Miner 1989;5:193–200.

    Google Scholar 

  55. Pun KK, Wong FHW, Wang C, Lau P, Ho PWM, Pun WK, et al. Vitamin D status among patients with fractured neck of femur in Hong Kong. Bone 1990;11:365–8.

    Google Scholar 

  56. Baker MR, McDonell H, Peacock M, Nordin BEC. Plasma 25-hydroxyvitamin D concentrations in patients with fractures of the femoral neck. BMJ 1979;1:589–90.

    Google Scholar 

  57. Benhamou CL, Tourliere D, Gauvain JB, Picaper P, Audran M, Jallet P. Calciotropic hormones in elderly people with and without hip fracture. Osteoporosis Int 1995;5:103–7.

    Google Scholar 

  58. Knorring JU, Slätis P, Weber TH, Helenius T. Serum levels of 25-hydroxyvitamin D and parathyroid hormone in patients with femoral neck fracture in Southern Finland. Clin Endocrinol 1982;17:189–94.

    Google Scholar 

  59. Weisman Y, Salama R, Harell A, Edelstein S. Serum 24,25-dihydroxyvitamin D and 25-hydroxyvitamin D concentrations in femoral neck fracture. BMJ 1978;2:1196–7.

    Google Scholar 

  60. Meller Y, Kestenbaum RS, Galinsky D, Shany S. Seasonal variation in serum levels of vitamin D metabolites and parathormone in geriatric patients with fractures in southern Israel. Isr J Med Sci 1986;22:8–11.

    Google Scholar 

  61. Lund B, Sorensen OH, Christensen AB. 25-Hydroxycholecalciferol and fractures of the proximal femur. Lancet 1975;II:300–2.

    Google Scholar 

  62. Rapin CH, Lagier R, Boivin G, Jung A, McGee W. Biochemical findings in blood of aged patients with femoral neck fractures: a contribution to the detection of occult osteomalacia. Calcif Tissue Int 1982;34:465–9.

    Google Scholar 

  63. Chalmers J, Conacher WDH, Gardner DL, Scott P, Osteomalacia: a common disease in elderly women. J Bone Joint Surg Br 1967;49:403–23.

    Google Scholar 

  64. Aaron JE, Gallagher JC, Nordin BEC. Seasonal variation of histological osteomalacia in femoral neck fractures. Lancet 1975;2:84–6.

    Google Scholar 

  65. Anderson I, Campbell AER, Dunn A, Runciman JBM. Osteomalacia in elderly women. Scott Med J 1966;11:429.

    Google Scholar 

  66. Campbell GA, Hosking DJ, Kemm JR, Boyd RV. How common is osteomalacia in the elderly? Lancet 1984;2:386–8.

    Google Scholar 

  67. Meunier J. Prevention of hip fractures. Am J Med 1993;95:S75–8.

    Google Scholar 

  68. Chapuy MC, Chapuy P, Meunier PJ. Effect of calcium and vitamin D supplements on calcium metabolism in the elderly. Am J Clin Nutr 1987;46:324–8.

    Google Scholar 

  69. Orwoll ES, McClung MR, Oviatt SK, Recker RR, Weigel RM. Histomorphometric effects of calcium on calcium plus 25-hydroxyvitamin D3 therapy in senile osteoporosis. J Bone Miner Res 1989;4:81–8.

    Google Scholar 

  70. Heikinheimo RJ, Inkovaaera JA, Harju EJ, Haavisto MC, Kaarel RH, Kataja JM. Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 1992;51:105–10.

    Google Scholar 

  71. Chapuy ME, Arlot MF, Duboeuf F, Brun J, Crouzet B, Arnaud S, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327:1637–42.

    Google Scholar 

  72. Chapuy ME, Arlot MF, Delmas PD, Meuniere PJ. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 1994;308:1081–2.

    Google Scholar 

  73. Ooms ME, Roos JC, Bezemer PD, Van der Vijgh WJF, Bouter LM, Lips P. Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 1995;80:1052–8.

    Google Scholar 

  74. Meunier PJ, Chapuy MC, Arlot ME, Delmas PD, Duboeuf F. Can we stop bone loss and prevent hip fractures in the elderly? Osteoporosis Int 1994;4:S71–6.

    Google Scholar 

  75. Lafarge H, Chapuy MC, Arlot ME, Rouillon A, Meunier PJ. Cost-benefit analysis of prevention of hip fracture with calcium and vitamin D3 in elderly women. J Bone Miner Res 1993;8(Suppl 1):abstr 25.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quesada-Gómez, J.M., Alonso, J. & Bouillon, R. Vitamin D insufficiency as a determinant of hip fractures. Osteoporosis Int 6 (Suppl 3), 42–47 (1996). https://doi.org/10.1007/BF01623764

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01623764

Keywords

Navigation